NM_002439.5:c.-5C>T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_002439.5(MSH3):c.-5C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000815 in 1,595,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002439.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH3 | NM_002439.5 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 24 | ENST00000265081.7 | NP_002430.3 | ||
MSH3 | NM_002439.5 | c.-5C>T | 5_prime_UTR_variant | Exon 1 of 24 | ENST00000265081.7 | NP_002430.3 | ||
DHFR | NM_000791.4 | c.-234G>A | 5_prime_UTR_variant | Exon 1 of 6 | ENST00000439211.7 | NP_000782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 24 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
MSH3 | ENST00000667069 | c.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 22 | ENSP00000499502.1 | |||||
MSH3 | ENST00000265081 | c.-5C>T | 5_prime_UTR_variant | Exon 1 of 24 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
DHFR | ENST00000439211.7 | c.-234G>A | 5_prime_UTR_variant | Exon 1 of 6 | 1 | NM_000791.4 | ENSP00000396308.2 | |||
MSH3 | ENST00000667069 | c.-5C>T | 5_prime_UTR_variant | Exon 1 of 22 | ENSP00000499502.1 | |||||
MSH3 | ENST00000670357.1 | n.-5C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 25 | ENSP00000499791.1 | |||||
MSH3 | ENST00000670357.1 | n.-5C>T | non_coding_transcript_exon_variant | Exon 1 of 25 | ENSP00000499791.1 | |||||
MSH3 | ENST00000670357.1 | n.-5C>T | 5_prime_UTR_variant | Exon 1 of 25 | ENSP00000499791.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151948Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000529 AC: 12AN: 226922Hom.: 0 AF XY: 0.0000160 AC XY: 2AN XY: 125116
GnomAD4 exome AF: 0.00000831 AC: 12AN: 1443992Hom.: 0 Cov.: 35 AF XY: 0.00000278 AC XY: 2AN XY: 718812
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151948Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74208
ClinVar
Submissions by phenotype
MSH3-related disorder Uncertain:1
The MSH3 c.-5C>T variant is located in the 5' untranslated region. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.037% of alleles in individuals of Latino descent in gnomAD and has been interpreted as uncertain in ClinVar (https://ncbi.nlm.nih.gov/clinvar/variation/1750993/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
This variant has not been reported in the published literature. The frequency of this variant in the general population, 0.00037 (12/32648 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect MSH3 mRNA splicing . Based on the available information, we are unable to determine the clinical significance of this variant. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.-5C>T variant is located in the 5' untranslated region (5’UTR) of the MSH3 gene. This variant results from a C to T substitution 5 nucleotides upstream from the first translated codon. This nucleotide position is not well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at